Clinical Pharmacology Study of NS-229 in Healthy male subjects (Phase I Study) (Drug-Drug Interaction Study with Prednisolone)
Phase 1
- Conditions
- inflammatory diseases
- Registration Number
- JPRN-jRCT2051210094
- Lead Sponsor
- Higashioka Masaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
1) Provided written informed consent
2) Japanese male subjects
3) Body mass index (BMI) >=18.5 and <25.0 kg/m2 at the time of screening tests and hospitalization
Exclusion Criteria
1) Subjects with active systemic infections
2) Subjects who may have latent tuberculosis, including subjects who have already been infected with tuberculosis
3) Subjects who are contraindicated for predonisolone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method